Selective targeting of α4β7/MAdCAM-1 axis suppresses fibrosis progression in chronic liver disease https://www.biorxiv.org/content/10.1101/2023.02.20.528201v1?med=mas
CleverLibre Social is an inclusive social instance for open discussion, learning, and community. All cultures welcome. Hate speech and harassment strictly forbidden.